NewslettersMesenchymal Cell NewsUncategorizedNeoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B CellsBy Justin.choi - February 4, 2022033Researchers characterized changes in the soft tissue sarcoma tumor immune microenvironment induced by standard neoadjuvant therapy with the goal of informing neoadjuvant immunotherapy trial design.[Clinical Cancer Research] 7992332 {7992332:BBBBBBBB} apa 50 1 171504 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract